.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Accenture
Merck
Medtronic
Julphar
Farmers Insurance
Citi
QuintilesIMS
Federal Trade Commission
Daiichi Sankyo

Generated: December 17, 2017

DrugPatentWatch Database Preview

Apotex Inc Company Profile

« Back to Dashboard

What is the competitive landscape for APOTEX INC, and what generic and branded alternatives to APOTEX INC drugs are available?

APOTEX INC has two hundred and twenty-two approved drugs.

There are sixteen tentative approvals on APOTEX INC drugs.

Summary for Apotex Inc

US Patents:0
Tradenames:174
Ingredients:166
NDAs:222
Drug Master File Entries: 2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex IncQUINAPRIL HYDROCHLORIDEquinapril hydrochlorideTABLET;ORAL076240-002Jan 26, 2006DISCNNoNo► Subscribe► Subscribe► Subscribe
Apotex IncPREDNISOLONEprednisoloneSYRUP;ORAL040571-001Aug 25, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe
Apotex IncTOBRAMYCINtobramycinSOLUTION/DROPS;OPHTHALMIC065087-001Feb 25, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe
Apotex IncCLOPIDOGREL BISULFATEclopidogrel bisulfateTABLET;ORAL076274-001May 17, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex IncALPRAZOLAMalprazolamTABLET, EXTENDED RELEASE;ORAL078449-003Nov 12, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex IncRIVASTIGMINE TARTRATErivastigmine tartrateCAPSULE;ORAL091072-004May 16, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex IncZIPRASIDONE HYDROCHLORIDEziprasidone hydrochlorideCAPSULE;ORAL077561-001Mar 2, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex IncMOEXIPRIL HYDROCHLORIDEmoexipril hydrochlorideTABLET;ORAL078454-002Jun 2, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex IncOLANZAPINEolanzapineTABLET, ORALLY DISINTEGRATING;ORAL091265-002Oct 24, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex IncCIPROFLOXACIN HYDROCHLORIDEciprofloxacin hydrochlorideSOLUTION/DROPS;OPHTHALMIC075928-001Jun 9, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Apotex Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apotex IncALKERANmelphalan hydrochlorideINJECTABLE;INJECTION020207-001Nov 18, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Mallinckrodt
Julphar
Johnson and Johnson
QuintilesIMS
Citi
Queensland Health
Fuji
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot